Targeted Genetics Company Profile

12:34 EDT 21st March 2018 | BioPortfolio

Targeted Genetics Corporation develops and commercializes molecular therapeutics that target the underlying cause of a variety of serious diseases that have significant unmet medical need. Our lead product candidate is being developed as a treatment for inflammatory arthritis, and additional programs target HIV/AIDS, congestive heart failure, Huntington's disease and hyperlipidemia. Our diverse pipeline has been built on a solid foundation of intellectual property related to gene delivery, and on our core capabilities in critical functions that include preclinical development, clinical and regulatory affairs and manufacturing of innovative gene-based product candidates. These assets and capabilities provide a broad spectrum of potential future market opportunities, as well as partnering or out-licensing opportunities. Targeted Genetics is based in Seattle, Washington, and has approximately 65 employees. The Company has been public since May 1994 and its stock trades on the NASDAQ Capital Market under the ticker symbol TGEN.


1100 Olive Way Suite 100
United States of America


Phone: 206 623 7612
Fax: 206 223 0288

News Articles [572 Associated News Articles listed on BioPortfolio]

Active genetics technology opens new horizons

(University of California - San Diego) Employing CRISPR/Cas9 advancements, UC San Diego researchers are using new active genetics technology to reveal new fundamental mechanisms that control gene acti...

Seattle Genetics, Pieris Pharma partner to advance immuno-oncology treatments

Seattle Genetics and Pieris Pharmaceuticals signed a licensing agreement to develop several targeted bispecific immuno-oncolo -More- 

Seattle Genetics public offering nets $659mm to fund Cascadian purchase

Seattle Genetics Inc. (targeted antibody-based cancer therapies) netted $659mm through a public offering of 13.27mm common shares (including the overallotment) at $52. Proceeds will fund the firm's ac...

Boston-Based Biotech Inks Immuno-Oncology Pact With Seattle Genetics

Seattle Genetics and Pieris today announced they have entered into a collaboration and license agreement with the goal of developing multiple targeted bispecific immuno-oncology treatments for solid t...

Seattle Genetics, Pieris enter into $1.2bn immuno-oncology collaboration

Seattle Genetics and Pieris Pharmaceuticals partnered to develop multiple targeted bispecific immuno-oncology treatments for solid tumors and blood cancers.

Seattle Genetics to Present at the Barclays Global Healthcare Conference 2018

Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that management will present at the Barclays Global Healthcare Conference 2018 on Wednesday, March 14, 2018 at 10:45 a.m. East...

Nazneen Rahman: In tune with genetics

bmj;359/oct18_4/j4732/FAF1faDuncan SmithBiographyNazneen Rahman is professor of human genetics at the Institute of Cancer Research in London and head of the Cancer Genetics Unit at the Royal Marsden.....

A New Edition of Genetics in Medicine Is Now Available

Genetics in Medicine (vol. 19, no. 5, 2017) is available online by subscription only. Articles include: “Diagnostic Cytogenetic Testing Following Positive Noninvasive Prenatal Screening Results...

PubMed Articles [1152 Associated PubMed Articles listed on BioPortfolio]

Genetics of Alzheimer's disease: From pathogenesis to clinical usage.

Alzheimer's disease (AD) is the most common type of dementia and has caused a major global health concern. Understanding the etiology of AD can be beneficial for the diagnosis and intervention of this...

Introduction to behavioral phenotypes in medical genetics.

Correction: Effect of Insulin Resistance on Monounsaturated Fatty Acid Levels: A Multi-cohort Non-targeted Metabolomics and Mendelian Randomization Study.

[This corrects the article DOI: 10.1371/journal.pgen.1006379.].

Medical genetics and genomic medicine in the United States. Part 2: Reproductive genetics, newborn screening, genetic counseling, training, and registries.

Review of genetics in the United States with emphasis on the prenatal, metabolic, genetic counseling, and training aspects of the field.

Targeted versus non-targeted HIV testing offered via electronic questionnaire in a Swiss emergency department: A randomized controlled study.

In Switzerland, the national HIV testing recommendations propose targeted testing. Although the emergency department (ED) is mentioned specifically as a site where HIV testing should take place, the t...

Clinical Trials [1355 Associated Clinical Trials listed on BioPortfolio]

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment

Prostate cancer is the most common cancer in men in the United Kingdom (UK) with over 40,000 men diagnosed each year. Prostate cancer (PrCa) can run in some families and research studies h...

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information ...

Virtual Reality Intervention in Cancer Genetics

The goal of this study is to evaluate a virtual reality-based intervention for training health care providers who are not genetics specialists to effectively communicate with and counsel p...

Genetics of Asthma and Bronchial Hyperresponsiveness

To investigate the genetics of asthma by reexamining a carefully characterized population of patients with asthma, and by studying their families.

Companies [558 Associated Companies listed on BioPortfolio]

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, couns...

Ambry Genetics Corporation

Ambry Genetics is a privately held healthcare company with the industry’s most comprehensive suite of genetic testing solutions, benefiting 90% of all U.S. patients covered b...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent ce...

Population Genetics

Harnessing The Power of Populations™ Population Genetics’ approach takes the process of genetic analysis one step further. It enables the elaboration and testing of distinct hypotheses...

ArborGen Inc.

ArborGen is revolutionizing productivity in forestry. ArborGen is the largest global supplier of seedling products and a leading provider of improved genetics to the forest indust...

More Information about "Targeted Genetics" on BioPortfolio

We have published hundreds of Targeted Genetics news stories on BioPortfolio along with dozens of Targeted Genetics Clinical Trials and PubMed Articles about Targeted Genetics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Targeted Genetics Companies in our database. You can also find out about relevant Targeted Genetics Drugs and Medications on this site too.

Quick Search


Relevant Topics

Arthritis is by definition the inflammation of one or more joints, characterized by swelling, pain, warmth, redness and diminished range of joint movement (Oxford Medical Dictionary). There are many different types; Noninflammatory; Osteoarthritis, N...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Corporate Database Quicklinks

Searches Linking to this Company Record